Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 15-ketoprostaglandin f2alpha

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 15-ketoprostaglandin f2alpha in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(15-ketoprostaglandin f2alpha)
Trials
(15-ketoprostaglandin f2alpha)
Recent Studies (post-2010) (15-ketoprostaglandin f2alpha)
9,1561875524134

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blank, ML; Feuerstein, G; Kopin, IJ; Krausz, MM; Snyder, F; Zukowska-Grojec, Z1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 15-ketoprostaglandin f2alpha

ArticleYear
Cardiovascular and sympathetic effects of l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious SHR and WKY rats.
    Clinical and experimental hypertension. Part A, Theory and practice, 1982, Volume: 4, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Dinoprost; Epinephrine; Heart Rate; Hemodynamics; Male; Norepinephrine; Platelet Activating Factor; Prostaglandins F; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Thromboxane B2

1982